2002

Schetelig, J., Thiede, C., Bornhauser, M., Schwerdtfeger, R., Kiehl, M., Beyer, J., Kroger, N., Hensel, M., Scheffold, C., Ho, A.D., Kienast, J., Neubauer, A., Zander, A.R., Fauser, A.A., Ehninger, G. & Siegert, W. (2002) Reduced non-relapse mortality after reduced intensity conditioning in advanced chronic lymphocytic leukemia. Ann Hematol, 81 Suppl 2, S47-48.

Thiede, C., Lutterbeck, K., Oelschlagel, U., Kiehl, M., Steudel, C., Platzbecker, U., Brendel, C., Fauser, A.A., Neubauer, A., Ehninger, G. & Bornhauser, M. (2002) Detection of relapse by sequential monitoring of chimerism in circulating CD34+ cells. Ann Hematol, 81 Suppl 2, S27-28.

Reuter, U., Roesler, J., Thiede, C., Schulz, A., Classen, C.F., Oelschlagel, U., Debatin, K.M. & Friedrich, W. (2002) Correction of complete interferon-gamma receptor 1 deficiency by bone marrow transplantation. Blood, 100, 4234-4235.

Kreuzer, K.A., Schmidt, C.A., Schetelig, J., Held, T.K., Thiede, C., Ehninger, G. & Siegert, W. (2002) Kinetics of stem cell engraftment and clearance of leukaemia cells after allogeneic stem cell transplantation with reduced intensity conditioning in chronic myeloid leukaemia. Eur J Haematol, 69, 7-10.

Illmer, T., Schuler, U.S., Thiede, C., Schwarz, U.I., Kim, R.B., Gotthard, S., Freund, D., Schakel, U., Ehninger, G. & Schaich, M. (2002) MDR1 gene polymorphisms affect therapy outcome in acute myeloid leukemia patients. Cancer Res, 62, 4955-4962.

Thiede, C., Steudel, C., Mohr, B., Schaich, M., Schakel, U., Platzbecker, U., Wermke, M., Bornhauser, M., Ritter, M., Neubauer, A., Ehninger, G. & Illmer, T. (2002) Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis. Blood, 99, 4326-4335.

Liu, H., Ye, H., Ruskone-Fourmestraux, A., De Jong, D., Pileri, S., Thiede, C., Lavergne, A., Boot, H., Caletti, G., Wundisch, T., Molina, T., Taal, B.G., Elena, S., Thomas, T., Zinzani, P.L., Neubauer, A., Stolte, M., Hamoudi, R.A., Dogan, A., Isaacson, P.G. & Du, M.Q. (2002) T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication. Gastroenterology, 122, 1286-1294.

Stolte, M., Bayerdorffer, E., Morgner, A., Alpen, B., Wundisch, T., Thiede, C. & Neubauer, A. (2002) Helicobacter and gastric MALT lymphoma. Gut, 50 Suppl 3, III19-24.

Schetelig, J., Kroger, N., Held, T.K., Thiede, C., Krusch, A., Zabelina, T., Dubiel, M., Rick, O., Bornhauser, M., Ehninger, G., Zander, A.R. & Siegert, W. (2002) Allogeneic transplantation after reduced conditioning in high risk patients is complicated by a high incidence of acute and chronic graft-versus-host disease. Haematologica, 87, 299-305.